Tim Urban is an author, speaker, and popular blogger best known for his blog, "Wait But Why." He is renowned for his engaging long-form articles and stick-figure illustrations that cover a wide range of topics, from procrastination to artificial intelligence. Tim graduated cum laude from Harvard University with a degree in Government and has co-founded several successful ventures, including ArborBridge and truePrep. His unique blend of humor and insight has earned him a large following and recognition as one of the internet's most captivating writers.

Kristen Fortney is the co-founder and CEO of BioAge Labs, a computational biology startup in Berkeley, California. She received her PhD in Medical Biophysics from the University of Toronto and completed her postdoctoral training at Stanford University. Kristen is an expert in developing bioinformatics approaches to investigate aging and age-related diseases. Her research focuses on computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity. As CEO, she leads BioAge Labs in its mission to develop therapies that target aging to increase healthspan and address chronic diseases.

Peter Diamandis is a visionary entrepreneur, physician, and author, best known as the founder and executive chairman of the XPRIZE Foundation, which designs and operates large-scale incentive competitions to solve global challenges. He is also the executive founder of Singularity University, a Silicon Valley institution focused on exponentially growing technologies. With degrees in molecular genetics and aerospace engineering from MIT and an M.D. from Harvard Medical School, Diamandis has founded over 25 companies in fields such as health-tech, space, and education. He is a New York Times bestselling author and a recognized leader, named by Fortune as one of the "World's 50 Greatest Leaders".

George Church is an American geneticist, molecular engineer, chemist, and serial entrepreneur, renowned for his pioneering work in personal genomics and synthetic biology. He is the Robert Winthrop Professor of Genetics at Harvard Medical School and a Professor of Health Sciences and Technology at Harvard University and MIT. Church is a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard University and has co-founded around 50 biotech companies through his Harvard lab. His innovative contributions have significantly impacted next-generation sequencing methods and companies, and he has been recognized as one of Time magazine's 100 most influential people in the world.

Matt Kaeberlein, PhD, is the CEO of Optispan, driving innovation in predictive, preventive, and personalized healthcare. A renowned expert in aging biology, he is also a professor at the University of Washington, where he has made significant contributions to the field of oral health sciences, pathology, and genome sciences. Kaeberlein co-directs the Dog Aging Project and serves as CEO of the American Aging Association. His research on longevity and aging has earned international recognition, and he has been a leader in advancing medical solutions to extend healthy human lifespans.

Omri Amriav-Drory is a scientist and entrepreneur, currently serving as the General Partner at NFX Bio. He is the Founder and CEO of Renewal Bio, a company focused on developing innovative solutions in the field of biotechnology. Omri previously founded Genome Compiler, which was acquired by Twist Bioscience, and has played a pivotal role in scaling and investing in influential techbio companies. His unique blend of scientific expertise and entrepreneurial experience makes him a significant figure in the techbio industry.

Adam Bataineh is a medical doctor and the founder of Numenor, an online longevity clinic based in London. He is dedicated to making cutting-edge health interventions accessible to everyone, with a focus on personalized, preventative healthcare. Adam's work at Numenor aims to extend healthspan by targeting key biomarkers associated with aging-related diseases and providing comprehensive health assessments and personalized treatment plans. His belief in the urgent need to address aging drives his mission to bring longevity medicine to a wider audience.

Robin Hanson is an associate professor of economics at George Mason University and a research associate at the Future of Humanity Institute at Oxford University. He is known for his pioneering work on prediction markets, also known as idea futures, and has been a key figure in developing these markets for various applications. Robin has authored several influential books, including "The Age of Em: Work, Love and Life When Robots Rule the Earth" and "The Elephant in the Brain: Hidden Motives in Everyday Life." His research spans a wide range of topics, from spatial product competition to the bioethics of healthcare, and he is a prominent advocate for futarchy, a form of governance based on prediction markets.

Joe Betts-LaCroix is an American scientist and entrepreneur known for his discoveries in biophysics and for creating the world's smallest personal computer. He is currently the co-founder and CEO of Retro Biosciences, a company focused on developing therapeutics to increase healthy human lifespan by ten years. Joe has a background in earth sciences, biophysics, and computer hardware, and has contributed to significant advancements in both scientific research and technology innovation.

David Barzilai is a physician, longevity consultant, and health coach, known for his expertise in geroscience and longevity medicine. As the founder and CEO of Healthspan Coaching LLC, he provides personalized health and longevity coaching, integrating the latest scientific research and technology. David is also an active member of the longevity community, engaging with scholars and practitioners on social media under the handle @agingdoc1. His work focuses on promoting healthy aging and optimizing healthspan through evidence-based practices and lifestyle interventions.

Allison Duettmann is the President and CEO of the Foresight Institute, where she directs programs on Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs. She is also the Founder of Existential Hope and has co-edited works on superintelligence and co-authored books on future technologies. Allison holds an MS in Philosophy & Public Policy from the London School of Economics, focusing on AI Safety. She is a prominent advocate for leveraging technology to create a positive long-term future for humanity.

Brian Kennedy is a scientist and entrepreneur, known for his significant contributions to the field of aging research. He has held leadership positions at several prominent institutions, including the Buck Institute for Research on Aging, where he served as President and CEO. Brian's work focuses on understanding the mechanisms of aging and developing interventions to promote healthy longevity. His research has been instrumental in advancing the field of biogerontology and has garnered widespread recognition.

Riva Tez is a free-thinking writer and philosopher known for her unconventional approach to exploring complex ideas. She is passionate about questioning societal taboos and delving into topics such as philosophy, theology, and consciousness. Riva's work is characterized by her deep curiosity and her ability to uncover forgotten or under-explored concepts. She combines her love for poetry and philosophy to challenge conventional thinking and inspire others to think more freely and creatively.

Chris Mirabile is the Founder and CEO of NOVOS, a pioneering consumer longevity biotech company dedicated to addressing the mechanisms of aging. Overcoming a brain tumor at a young age, Chris has devoted his life to health and longevity, achieving a biological age significantly younger than his chronological age through a balanced lifestyle and innovative health practices. He has been featured in numerous publications and has spoken at various conferences about his journey and the science behind slowing aging. Chris is passionate about making longevity achievable and accessible for all through scientifically validated, over-the-counter formulations and best-in-class biological age tests.

Vincent Weisser is a dedicated advocate for decentralized science and AI, known for his work on projects like VitaDAO, which funds longevity research, and Molecule, a platform for scientific funding. He is passionate about democratizing access to cutting-edge technologies and scientific progress, aiming to create a future where advanced AI and biotechnology are accessible to all. Vincent's diverse interests and contributions span across AI, biotechnology, energy, and more, making him a key figure in the tech and science communities.

Anastasiya Giarletta is a prominent figure in the longevity and biotech sectors, serving as an advisor and co-founder of Aikora Health and an investor at R42 Group. Based in Silicon Valley and London, she focuses on connecting venture funds, angels, and entrepreneurs within the early-stage longevity ecosystem. Anastasiya is also a Teaching Assistant at Stanford University School of Medicine, where she lectures on Longevity Venture Capital and Healthcare Venture Capital. Her extensive network and expertise make her a key influencer in advancing healthcare and human aging technologies.

Phil Newman is the Founder and CEO of Longevity.Technology, a leading media and investment platform focused on the longevity megatrend. He has held multiple C-level management positions, applying his marketing and business development expertise in sectors such as longevity, IoT, bionics, medical devices, biopharma, and 3D manufacturing. Phil's work aims to bring together innovators and investors to commercialize companies that will form the longevity economy.

Daniel Ives is the CEO and founder of Shift Bioscience, a company dedicated to reversing cellular aging using AI-guided cellular rejuvenation techniques. With a background in mitochondrial biology from the University of Cambridge, Daniel has been at the forefront of developing innovative solutions to combat age-related diseases. His work focuses on leveraging advanced machine learning and epigenetic aging clocks to discover new therapeutic interventions that can extend human healthspan.

Dr. Emil Kendziorra is the Founder and CEO of Tomorrow.Bio, a startup dedicated to advancing biostasis (cryonics) research and providing human cryopreservation services. He graduated summa cum laude from the University of Göttingen and has extensive experience in cancer research and entrepreneurship. Dr. Kendziorra has founded and led multiple tech and medical startups, including MedLanes and onFeedback. His vision is to build an organization that significantly contributes to the field of cryonics and promotes public awareness about its potential.

Andrew Steele is a scientist, writer, and campaigner based in Berlin. He holds a PhD in physics from the University of Oxford and has transitioned to computational biology, focusing on aging research. Andrew is the author of "Ageless: The New Science of Getting Older Without Getting Old" and regularly contributes to major publications like the Wall Street Journal and WIRED. He is also a popular science presenter on television and YouTube, making complex scientific concepts accessible to a broad audience.

Nils Regge is a serial entrepreneur and investor with a strong passion for health and biotechnology. He is the co-founder and Managing Director of Apollo Health Ventures, a venture capital fund focused on aging and age-related diseases. Nils has founded several successful companies, including TruVenturo and HomeToGo, and has been involved in numerous financing rounds. His expertise in growing early-stage startups and his commitment to advancing biomedicine make him a key player in the longevity sector.

Kai Micah Mills is the CEO of Cryopets, a startup specializing in cryopreservation for pets, and a co-founder of CryoDAO, a decentralized organization funding cryonics research. With a background as a tech entrepreneur and Thiel Fellow, Kai is dedicated to advancing cryopreservation technologies and making significant contributions to the field of life extension.

Clara Fernandez Porta is a visionary leader and innovator in the field of longevity, known for her roles as the CEO and co-founder of RxLongevity and the founder of Europe's largest Longevity Clinic for Seniors. She has been recognized as one of the Top 100 Female Leaders and Top 100 Forbes Creatives in Spain, and is also a celebrated author with Penguin Editorial, contributing significantly to the discourse on healthy aging and longevity. Her work focuses on empowering seniors to live longer, healthier lives through personalized health plans and cutting-edge technology.

Karl Pfleger is a prominent angel investor and advocate for longevity research, known for his significant contributions to the biotech industry. He is an investor in Repair Biotechnologies, focusing on gene therapy for age-related diseases, and runs Aging Biotech Info, a valuable resource for the longevity community. Karl's background in machine learning and his dedication to supporting groundbreaking research make him a key figure in the fight against aging.

Paul Kohlhaas is a visionary entrepreneur and Web3 engineer, best known for co-founding Molecule, a decentralized biopharma marketplace that leverages blockchain technology to streamline drug discovery and development. He is also a founding member of BIO Protocol, a decentralized autonomous organization focused on funding biomedical research. Paul's innovative work aims to democratize access to biotech funding and accelerate the development of new medicines through transparent and efficient collaboration.

Raiany Romanni is a distinguished researcher, bioethicist, and advocate for longevity science. Currently serving as the Research Director for Longevity Policy and Ethics at the Amaranth Foundation, she explores the intersection of ethics and cutting-edge healthcare advancements. Raiany has contributed her expertise to XPRIZE Healthspan and the Foresight Institute, and served as a Futurist-in-Residence at PHD Ventures. She’s also a prominent writer and speaker on longevity, ethics, and healthcare policy, influencing global conversations on aging and well-being. Her work blends rigorous research with a profound commitment to social impact.

Alfredo Andere is the co-founder and CEO of LatchBio, a platform that provides biology companies with the tools to store, transform, and analyze large data sets. Before founding LatchBio, he worked as a Data Engineer at Facebook and a Software Engineer at Google Brain, gaining valuable experience in handling large-scale data. Alfredo and his co-founders envisioned bringing high-quality computational infrastructure to the field of biology, and they dropped out of their senior year at UC Berkeley to pursue this goal. Since its inception, LatchBio has raised significant funding and serves numerous biotech companies.

Charles Brenner, PhD, is the Alfred E. Mann Family Foundation Chair in Diabetes & Cancer Metabolism at the Beckman Research Institute, City of Hope. A world-renowned expert in nicotinamide adenine dinucleotide (NAD+) metabolism, Brenner’s pioneering research has transformed understanding of metabolic stress and NAD+ systems. His lab uses gene discovery, metabolomics, and animal modeling to uncover pathways disrupted in disease. Previously, he held leadership roles at the University of Iowa and Dartmouth College. Dr. Brenner also serves as Chief Scientific Advisor at ChromaDex, advancing NAD+ therapeutics for human health.

Ole Mensching, Ph.D., is the co-founder and General Partner of Apollo Ventures, a venture capital fund dedicated to aging and age-related diseases. He has a strong background in investment and operations, previously co-founding CareerTeam, a successful headhunting agency. Ole holds a Ph.D. from the University of California, Berkeley, and the University of Cologne, and his expertise in HR and team building has been instrumental in supporting Apollo's portfolio companies.

Caitlin Lewis is the Director of Project Pipeline and Strategy at the LEV Foundation, where she plays a crucial role in evaluating progress and identifying therapeutic targets in the field of longevity. Introduced to the longevity field in 2017 through the SENS Research Foundation's MitoSENS project, Caitlin has been instrumental in developing strategies for nascent projects and facilitating their advancement. Her work focuses on promoting research to prevent and reverse age-related diseases, aiming to improve human healthspan.

Matthew Scholz is the Founder and Chief Executive Officer of Oisín Biotechnologies, a company pioneering gene therapy to target senescent cells and combat age-related diseases. He previously co-founded Immusoft and has been instrumental in developing innovative biotechnological solutions. Matthew's work focuses on creating therapies that can extend healthy lifespan and improve quality of life. His vision and leadership in the field of biotechnology make him a significant figure in the quest for longevity and healthspan enhancement.

Laurence Ion is a longevity advocate, entrepreneur, and investor dedicated to bringing aging under medical control. As the Founding Steward and Strategy Advisor at VitaDAO, he focuses on funding aging research projects and spinning out longevity biotech startups. Laurence is also the Co-initiator of Vitalia.city, a decentralized city aimed at accelerating drug development, and a Core member at JellyfishDAO, where he helps create inspiring content about longevity. His work aims to extend healthy lifespans through innovative and collaborative approaches.

Peter Fedichev is an entrepreneur and scientist with over 20 years of experience in academic research and biotech business. He is the founder of Gero, a longevity startup focused on developing therapies to extend a healthy human lifespan. Peter's scientific background lies in condensed matter physics, biophysics, and bioinformatics. His work aims to uncover the principles of aging and develop interventions to promote healthy longevity.

Jean Hebert is a distinguished scientist and entrepreneur, currently serving as a Program Manager at ARPA-H, where he focuses on health science futures. He previously held faculty positions at the Albert Einstein College of Medicine, specializing in genetics and neuroscience. Jean is the founder of BE Therapeutics, a company dedicated to reversing age-related damage to brain tissue. His research explores stem cell transplantation, neurodegeneration, and cortical health, aiming to develop regenerative therapies for aging tissues.

Laura Minquini is a longevity and women's health entrepreneur, known for her work in branding and luxury design. She has collaborated with prestigious companies such as Louis Vuitton, Apple, and Amazon. Laura is the founder of MYKIGAI, a discovery and recommendation platform for longevity, and the core lead of AthenaDAO, a decentralized collective funding women's health research. Her mission is to leverage her expertise to make science work for women, promoting healthier aging and well-being.

Dylan Livingston is the Founder and President of the Alliance for Longevity Initiatives (A4LI), a non-profit organization focused on advocating for policies that promote healthy human lifespan. He has a background in grassroots political organizing and has worked with various political campaigns, including the Biden campaign in Pennsylvania. Dylan is passionate about increasing equitable access to next-generation therapies and has been involved in the longevity community since childhood, influenced by his father's early-stage investments in futuristic technologies.

Sebastian Brunemeier is a biotech venture capitalist and company builder focused on longevity and regenerative medicine. He is the co-founder and General Partner of Healthspan Capital and the CEO and founder of ImmuneAGE Bio, a company dedicated to immune system rejuvenation. Sebastian has co-founded several longevity biotech companies, contributing to significant advancements in the field. His extensive experience and dedication to improving human healthspan have made him a respected figure in the biotech industry.

David Gobel is a philanthropist, entrepreneur, inventor, and futurist, best known for co-founding the Methuselah Foundation, which focuses on extending healthy human lifespans through regenerative medicine and biotechnology. He has been a driving force in promoting the concept of longevity escape velocity and has supported numerous projects and companies aimed at combating age-related diseases. David's visionary work continues to inspire advancements in the field of life extension.

Patri Friedman is a prominent libertarian and anarcho-capitalist, known for founding The Seasteading Institute, which explores the creation of sovereign ocean colonies. He is also the General Partner at Pronomos Capital, a venture capital firm focused on developing experimental cities in developing countries. Patri's innovative approaches to governance and urban development continue to inspire discussions on alternative political and social systems.

Adam Gries is a serial entrepreneur with 16 years of experience building and scaling consumer software. He has founded and sold five companies, including products that reached over 30M monthly active users. His ventures span gaming, social media, fashion ecommerce, and mobile edtech, where he’s excelled as a product-driven, technical CEO. In recent years, Adam has focused on longevity as an angel investor (Loyal, NOVOS), mentor (Harvard Innovation Labs), and influencer. He co-founded vitalism.io, runs longevitystate.com, and launched Tokyo Longevity Summit. A dedicated biohacker, Adam built his own elite health optimization playbook.

Mark Lutter is the Founder and Executive Chairman of the Charter Cities Institute, a nonprofit organization dedicated to building the ecosystem for charter cities. He is also the CEO of Braavos Cities, a charter city development company. With a PhD in economics from George Mason University, Mark's work focuses on innovative governance and economic development through the creation of new cities. His vision is to demonstrate better governance mechanisms and attract talent to these new urban centers.

Anar Isman is the co-founder and CEO of AgelessRx, a telemedicine platform dedicated to slowing down the aging process through scientifically-backed interventions. With a background in investment management, Anar transitioned to the field of longevity science driven by a desire to make a meaningful impact on human health. He believes in making cutting-edge longevity treatments accessible to everyone and is passionate about advancing the field to help people live healthier, longer lives.

Virginia Gambardella is the founder of Anapana and co-host of the Tressessanta podcast, ranked among Italy's top 100. She is passionate about building communities around mental and physical well-being, having grown a community of 300K across social media platforms. With a background in strategy and operations, Virginia has worked at McKinsey & Company and Serenis, where she led operations. Her entrepreneurial journey includes founding Moebius Milano and buoono.farm. A Bocconi graduate, she brings a unique mix of academic excellence and hands-on experience in diverse sectors.

Aykut Karaalioglu is an accomplished entrepreneur and investor, best known for founding MobileAction, a company specializing in app discovery and optimization. He has held various leadership roles, including CEO of SearchAds.comand Growth Lead at ScoreBeyond. Aykut is also an active angel investor and advisor to several startups, leveraging his extensive experience in product management and user acquisition to drive innovation and growth in the tech industry.

Geoffrey Miller, PhD, is a renowned professor of evolutionary psychology at the University of New Mexico and a Stanford alumnus. An expert in sexual selection and human behavior, he has authored influential books shaping the field. A key figure in the Effective Altruism movement, Miller focuses on AI safety, existential risks, and mitigating global catastrophic threats to align artificial intelligence with human values. As a consultant, he applies evolutionary psychology to consumer behavior and market research, bridging academic insights with practical applications to drive innovation and societal impact.

Matthew "Oki" O'Connor is the Co-CEO of Cyclarity Therapeutics, a company focused on developing treatments for cardiovascular diseases through innovative cyclodextrin technology. With a Ph.D. in Biochemistry and extensive research experience in aging and regenerative medicine, O'Connor has made significant contributions to the field. His work aims to eliminate toxic oxidized cholesterol, a major factor in atherosclerosis, and improve overall healthspan.

Christine Peterson is a visionary leader and advocate for emerging technologies, best known for co-founding the Foresight Institute, which focuses on nanotechnology and its long-term impacts. She is credited with coining the term "open source software," highlighting her influence on both technology and intellectual property. Christine is also an author and lecturer, sharing her insights on nanotechnology, AI, and longevity to educate the public and policymakers about the potential of these transformative fields.

Alejandro Ocampo is a prominent scientist and researcher, currently a professor at the University of Lausanne. He is renowned for his pioneering work in cellular reprogramming and its potential to reverse aging. Ocampo's research focuses on understanding the mechanisms of aging and developing therapeutic interventions to extend healthspan. His innovative approaches and dedication to advancing the field of longevity science have earned him recognition and respect in the scientific community.

Mac Davis is the founder of Minicircle, a pioneering company focused on revolutionizing gene therapy. With a mission to enhance human health and sovereignty, he developed a reversible human genetic enhancement protocol that uses non-inflammatory, non-heritable plasmids to safely introduce genes into the body without altering the genome. Mac’s innovative approach challenges traditional medical practices, offering a fast, accessible, and ethical alternative to lifelong treatments. His work aims to empower individuals and communities, ensuring that gene therapy is available to all, free from the constraints of the current healthcare system.

John Davis is a philosopher and author, best known for his work "New Methuselahs: The Ethics of Life Extension." In this book, Davis explores the ethical implications of extending human life, addressing issues such as desirability, unequal access, and potential overpopulation. His philosophical discussions provide a comprehensive guide to the ethical considerations of life extension, making a compelling case for funding research in this field.

Joseph Everett, also known as WIL, is the creator of the popular YouTube channel "What I've Learned." His content focuses on connecting the dots, making conclusions, and weighing them against modern dogma. Joseph covers a wide range of topics, including health, productivity, cognitive enhancement, and general self-improvement. His goal is to provide viewers with actionable takeaways that can be applied to daily life. Joseph's work is appreciated for its insightful and evidence-based approach to complex subjects.

Breanna Deutsch is a policy expert and author, known for her work in political communications and advocacy for life extension technologies. She is the Secretary of the Board at A4LI and the author of "Finding the Fountain: Why Government Must Unlock Biotech's Potential to Maximize Longevity." Breanna's efforts focus on encouraging policymakers to support aging research and promote healthier lifespans through government initiatives.

Patrick Linden is a philosopher and author, known for his work on the ethics of life extension and the philosophy of death. He has taught at various prestigious institutions, including Lund University, UCL, and NYU. His book, "The Case Against Death," argues that death is an evil that should be combated through anti-aging science and radical life extension. Linden's work challenges traditional views on mortality and advocates for a future where humans can live significantly longer, healthier lives.

Derya Unutmaz, MD, is a distinguished professor at The Jackson Laboratory, renowned for his pioneering work on human T cell differentiation, activation, and regulation in immunity, diseases, and aging. With a medical degree from Marmara University, Istanbul, he also holds a concurrent professorship at the University of Connecticut Health Center. Dr. Unutmaz’s research has transformed understanding of T cell dysfunction in diseases like HIV and chronic fatigue syndrome. His work aims to optimize immune responses and develop therapies that combat age-related diseases, advancing healthier aging and immune system treatments.

Jun Axup is a biotechnologist and entrepreneur, currently serving as the Chief Operating Officer at E11 Bio, a non-profit focused on building high-throughput molecular tools to map the brain connectome. She previously held the position of Chief Science Officer and Partner at IndieBio, where she funded and advised over 160 companies working on improving human and planetary health. Jun holds a PhD in chemical biology from the Scripps Research Institute and has co-founded multiple startups in fields such as immuno-oncology, protein engineering, and lab automation robotics. Her passion for brain longevity and innovative biotechnological solutions drives her work.

Andrew Brack is a distinguished scientist and entrepreneur, currently serving as the Program Manager for Proactive Health at ARPA-H. He previously co-founded Arrive Bio, a biotechnology company that uses machine learning to identify drugs for age-related diseases. Andrew has a Ph.D. in molecular biology and biophysics from King’s College London and has held faculty positions at UCSF and Stanford University. His research focuses on the cellular and molecular mechanisms of skeletal muscle repair during aging.

Adeel Khan is a Canadian Board Certified Physician and a leading figure in regenerative medicine and longevity. As the founder of Eterna Health Clinics, he is recognized for his innovative work in stem cell therapy and anti-aging treatments. Dr. Khan has gained global recognition for treating high-profile clients, including celebrities and elite athletes. His dedication to advancing regenerative medicine and improving health outcomes has made him a respected name in the field.

Marco Quarta is a distinguished scientist and entrepreneur, currently serving as the Co-founder, President & CSO of Rubedo Life Sciences. He holds a Ph.D. in Neuroscience from the University of Padua and has conducted post-doctoral research in aging and stem cell biology at Stanford University. Marco has over 20 years of experience in the fields of aging, stem cells, and regenerative medicine, and has co-founded several biotech companies. His work focuses on developing treatments for age-related diseases and extending healthspan by targeting pathological cells involved in the aging process.

Parmita Mishra is a computational biologist and entrepreneur, known for founding Precigenetics, a company focused on developing advanced non-invasive diagnostic tools that integrate biophotonics with machine learning. She is dedicated to pushing the boundaries of healthcare technology, particularly in the field of non-invasive cancer diagnostics. Parmita's work aims to enhance the identification of molecular signatures unique to cancerous cells, leveraging machine learning algorithms to improve detection and classification.

Morten Scheibye-Knudsen is an associate professor at the University of Copenhagen, where he leads the Scheibye-Knudsen Group. His research focuses on understanding the cellular and organismal consequences of DNA damage, with the goal of developing interventions to combat age-related diseases such as Alzheimer's and Parkinson's. Morten's work has shown that replenishing certain metabolites altered by DNA damage can influence the aging process in model organisms, suggesting potential therapeutic approaches for healthier aging.

Max More is a philosopher and futurist known for his work on transhumanism and the philosophy of extropy. He is the founder of the Extropy Institute and has served as President and CEO of the Alcor Life Extension Foundation. Max holds a degree in Philosophy, Politics, and Economics from Oxford University and a PhD in Philosophy from the University of Southern California. His writings and ideas have significantly influenced the transhumanist movement, focusing on the potential of emerging technologies to enhance human capabilities and extend life.

Mahdi Moqri, Ph.D., is a Harvard Faculty member, computational biologist, and the founding director of the Biomarkers of Aging Consortium. His interdisciplinary expertise spans omics, bioinformatics, and computational methods to explore the molecular mechanisms of aging and develop innovative therapies for age-related diseases. As director, he leads international collaborations to validate blood-based biomarkers of aging, with research published in Cell and Nature Medicine. Previously, Dr. Moqri completed a postdoctoral fellowship at Stanford University and has raised over $1M to advance aging research. He is passionate about enhancing human health and longevity.

Eli Mohamad is a serial entrepreneur and scientist, currently serving as an Entrepreneur in Residence at Narwhal Sciences, where he is incubating the Fraktus Protocol. He is a core team member of CryoDAO, focusing on advancing cryopreservation research, and has co-founded several organizations, including X-Therma and the Organ Preservation Alliance. Eli's work spans various cutting-edge fields, from tissue preservation to decentralized science, showcasing his commitment to innovation and scientific progress.

John Cumbers is a British molecular biologist and entrepreneur based in the San Francisco Bay Area. He is the founder and CEO of SynBioBeta, an organization that promotes synthetic biology to build a more sustainable universe. John also founded BetaSpace, a space settlement innovation network, and is an operating partner at DCVC, a venture capital firm focused on biotechnology investments. His work at NASA and his contributions to synthetic biology have earned him multiple awards and recognition in the field.

Dr. Vittorio Sebastiano is an Associate Professor at Stanford University’s School of Medicine and the Founder and Chair of the Scientific Advisory Board at Turn Biotechnologies, a company pioneering epigenetic rejuvenation. His research spans reproductive biology, stem cell biology, and aging, with a focus on pluripotent stem cells and germ cell development. He also serves on several prestigious advisory boards, including Dior Science’s ReverseAging and the Biomarkers of Aging Consortium. Dr. Sebastiano’s groundbreaking work has been recognized by the AFAR Junior Investigator Award, advancing science toward reversing aging at the cellular level.

Reason is the co-founder and CEO of Repair Biotechnologies, pioneering solutions to combat aging and extend human healthspan. An active angel investor in the longevity sector, he has backed companies like Oisin Biotechnologies and Leucadia Therapeutics. As a passionate patient advocate, Reason supports fundraising and outreach efforts for organizations like the Methuselah Foundation and SENS Research Foundation. He is also the founder and writer of Fight Aging!, a prominent biotechnology news and commentary platform. Before his biotechnology career, Reason was a consultant in the software industry.

Eric Verdin is a distinguished Belgian geroscientist and the President and CEO of the Buck Institute for Research on Aging. With a medical degree from the University of Liege and additional training at Harvard Medical School, Dr. Verdin's research focuses on the epigenetic regulation of aging, particularly the roles of sirtuins and NAD in the aging process1. He has published over 210 scientific papers and holds more than 15 patents. Dr. Verdin is also a Professor of Medicine at the University of California, San Francisco, and serves on the scientific advisory boards of several organizations, including the Longevity Science Foundation1.

Arkadi Mazin is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. Arkadi is dedicated to promoting the idea that life extension is an achievable and noble goal that deserves greater attention and action from society.

Hugo Bailly is the co-founder of Erectus DAO, a decentralized autonomous organization focused on advancing regenerative medicine and stem cell therapies. With a background in urology and extensive research experience, Hugo is dedicated to exploring innovative treatments for conditions such as erectile dysfunction and Peyronie's disease. His work aims to harness the potential of stem cells to improve patient outcomes and promote overall health.

Jason Sorens is an American political scientist and conservative libertarian activist, best known for founding the Free State Project in 2001. He holds a PhD in political science from Yale University and a BA in economics and philosophy from Washington and Lee University. Jason has taught at several prestigious institutions, including Yale, Dartmouth, and the University at Buffalo. His research focuses on fiscal federalism, public policy in federal systems, secessionism, and ethnic politics. He is also a Senior Research Fellow at the American Institute for Economic Research (AIER) and president of the Ethics and Economics Education of New England (E3NE).

Andrew Verbinnen is a co-founder of HairDAO, a decentralized science (DeSci) project aimed at tackling hair loss through innovative funding and research models. With a background in Government from Hamilton College and experience in private equity and cryptocurrency, Andrew transitioned to the DeSci space to address the misaligned incentives in pharmaceutical research. His work focuses on leveraging blockchain technology to democratize early-stage research and improve patient outcomes.

Jamie Justice, Ph.D., is the Executive Director of XPRIZE Healthspan and Vice President of the Health Domain at the XPRIZE Foundation. In these leadership roles, she drives global initiatives and incentivized competitions focused on advancing solutions to improve human health and aging. Dr. Justice also serves as an Adjunct Assistant Professor at Wake Forest University School of Medicine and has extensive research experience in age-related motor dysfunction. With a background in aging research, she is dedicated to pushing the boundaries of innovation to extend healthy human lifespan and optimize quality of life.

Vera Gorbunova is a distinguished biologist and the Doris Johns Cherry Professor at the University of Rochester, where she also co-directs the Rochester Aging Research Center. She earned her B.Sc. from Saint Petersburg State University and her Ph.D. from the Weizmann Institute of Science. Gorbunova's pioneering research focuses on the mechanisms of aging and cancer resistance, particularly in long-lived mammals like the naked mole rat. Her work has identified high molecular weight hyaluronan as a key mediator of cancer resistance, earning her recognition and numerous awards in the field of aging research.

Gennady Stolyarov II is a Belarusian-American libertarian and transhumanist writer, actuary, and civil servant. He is best known for his book "Death is Wrong," which argues that death is an enemy to be overcome through technology. Gennady is also the Chairman of the Transhumanist Party, advocating for life extension and the use of science and technology to enhance human capabilities.

Ronjon Nag is a British-American inventor, entrepreneur, and educator, known for his pioneering work in mobile technology and artificial intelligence. He is the Founder and President of the R42 Group, a venture capital firm investing in AI and longevity companies, and an Adjunct Professor in Genetics at the Stanford School of Medicine. Ronjon has co-founded several successful companies, including Lexicus and Cellmania, and his innovations have been instrumental in advancing mobile technology. His work continues to focus on the intersection of AI and biology, aiming to create solutions for healthier aging.

Kenneth Scott is an 81-year-old biohacker and longevity enthusiast with a biological age of 18. He has a diverse background, including roles as a mathematician, economist, and aeronautical engineer in the Royal Canadian Air Force. Kenneth is also a biotech investor and real estate developer. He and his wife spend significant resources on experimental treatments to reverse aging and have invested in biotech companies focused on longevity. Kenneth is a prominent figure in the longevity community, advocating for the potential of extended human lifespan and immortality.

Kevin Caldwell is the co-founder, President, and CEO of Ossium Health, a pioneering bioengineering company focused on creating the world's first bone marrow bank for transplants. With a background in physics and economics from MIT and a JD from Harvard Law School, Kevin has also worked as an Engagement Manager at McKinsey and a Senior Investment Associate at Bridgewater Associates. His diverse experience and dedication to improving human health through innovative solutions make him a significant figure in the biotech industry.

Mark Hamalainen is a visionary scientist and entrepreneur dedicated to extending human lifespan through innovative biotechnology. As the co-founder and co-executive director of the Longevity Biotech Fellowship, he focuses on fostering a community of researchers and innovators working on breakthrough technologies to combat aging. His career has spanned from manual bench work in academia to lab automation at Synthego, and now to building the longevity movement. Mark is passionate about finding higher leverage methods to accelerate progress in the field of longevity.

Petr Sramek is a visionary entrepreneur and investor dedicated to advancing human health and longevity. As the co-founder, chairman, and managing partner of Longevitytech.fund, he focuses on supporting innovative startups that aim to extend healthy lifespans. Petr is also the founder and CEO of HealthyLongevity.clinic and HealthyLongevity.cafe, where he works on personalized health strategies and longevity solutions. With a background in engineering and extensive experience in the tech industry, Petr is committed to building the infrastructure needed to accelerate the adoption of health-span improving technologies.

Irina Conboy, PhD, is a Professor of Bioengineering at the University of California, Berkeley, where she leads groundbreaking research on aging and rejuvenation. As the head of the Conboy Laboratory, her work has advanced understanding of how aging impacts stem cells and tissues. Notable for her innovative use of heterochronic parabiosis and blood apheresis, Dr. Conboy aims to develop therapies that reverse age-related decline, promoting healthier aging and tissue regeneration to extend lifespan and improve quality of life in older adults.

Mgoes is the co-founder of BiohackerDAO, a citizen science organization dedicated to data-driven self-optimization and radical human enhancement. He advocates for a minimalist, evidence-based approach to longevity, rigorously testing interventions and eliminating those that don't show clear, consistent improvements in his biomarkers. Mgoes focuses on actions that offer significant leverage, optimizing his daily routine for maximum impact. He is passionate about combining science and community collaboration to push the boundaries of human potential.

Ari Tulla is a San Francisco-based entrepreneur and the co-founder and CEO of Elo Health, a precision nutrition service transforming food from the cause of disease to medicine. With a background as CEO of Quest Analytics and co-founder of BetterDoctor, Ari has a proven track record of leading companies through pivotal growth stages. He is also an active angel investor with a portfolio of over 50 startups, including Virta Health and Oura. Outside of work, Ari enjoys rock climbing, surfing, and spending time with his family.

Adam Marblestone is CEO of Convergent Research, an organization pioneering new models to launch focused, high-impact research projects tackling critical scientific challenges. With a deep interest in longevity, Adam previously served as Research Director for Longevity at Astera Institute and has advanced science moonshots as an Innovation Fellow at Schmidt Futures. His career includes research leadership roles at MIT, DeepMind, and Kernel, where he bridged fields like AI, neuroscience, and biotechnology. Adam’s visionary approach aims to accelerate scientific progress, including breakthroughs to extend healthspan and combat aging.

Martin Borch Jensen is the co-founder and CSO of Gordian Biotechnology, focused on developing pooled in vivo therapeutic screenings to address aging-related diseases. He has a rich background in aging biology, mitochondrial health, and neurodegenerative diseases, with key publications in Cell Metab and Nature. Jensen holds a prestigious NIH K99/R00 award and previously studied DNA repair mechanisms in aging at the National Institute on Aging. In addition to his leadership role at Gordian, he serves on multiple scientific advisory boards and co-authored a popular science book on intermittent fasting and aging.

Tyler Golato is a Partner at Triplicate and a co-founder of Molecule GmbH, a company focused on advancing decentralized science and biotechnology. With a strong background in research, he has co-initiated several BioDAOs, including VitaDAO, to fund cutting-edge longevity research. Tyler has also invested in and mentored numerous biotech ventures, such as Marathon Fusion and BeakerDAO. His past experience includes working at the National Institutes of Health and Johns Hopkins, where he conducted pioneering work in oncology and aging. Tyler is a passionate advocate for innovation in science and technology.

Farbood Nivi is an accomplished entrepreneur and product leader, best known for founding Grockit, an online collaborative learning platform powered by machine learning, which was later acquired by Kaplan. He has also co-founded Coinmine, a company focused on making cryptocurrency mining accessible to everyone. With a background in psychology from the University of Michigan, Farbood continues to drive innovation in the tech and education sectors, leveraging his extensive experience to create impactful and user-friendly solutions.

Natalie Kuhn is the founder of Make The Sun, a transformative consulting and event company that empowers individuals and organizations to embrace change through mindfulness and inner solutions. A seasoned leader, she co-led The Class by Taryn Toomey, driving its growth and global expansion while promoting wellness and inclusivity. As a founding teacher, she cultivated a community of empowered individuals. Natalie has also been a key player in the wellness industry, inspiring positive change through her strategic leadership, public speaking, and advocacy for diversity in leadership.

Anatoly Karlin is a blogger, independent researcher, and thought leader with a background in economics. Since 2008, he has explored diverse topics, including world politics, transhumanism, and the future of human progress. Anatoly is the inventor of groundbreaking concepts such as the Age of Malthusian Industrialism, the Katechon Hypothesis, and Elite Human Capital, offering unique frameworks for understanding societal evolution and elite dynamics. Known for his analytical rigor and intellectual creativity, Anatoly provides deep insights that challenge conventional perspectives on economics, technology, and global development.

Mike Conboy, PhD, is a leading Research Scientist at the University of California, Berkeley, specializing in aging and rejuvenation research. As a key member of the Conboy Laboratory, he collaborates with his wife, Irina, to explore how aging affects stem cells and tissues. His work on heterochronic parabiosis and blood apheresis has shed light on potential therapies to reverse age-related damage and enhance tissue repair. Dr. Conboy is dedicated to advancing methods that could significantly improve healthspan and extend the healthy human lifespan.

John Schloendorn is a scientist and entrepreneur, known for founding Gene and Cell Technologies, where he serves as CEO. He previously led ImmunePath, a venture-backed regenerative medicine startup, and has also served as the Director of the SENS Foundation’s intramural Research Center. John's work focuses on developing therapies for age-related diseases, and he holds several patents and publications in the field of regenerative medicine.

Justin Rebo is the co-founder and CEO of Kind Bio, a biotechnology company focused on developing innovative solutions to extend healthy human lifespans. His work involves leveraging cutting-edge technologies to create therapies that target aging and age-related diseases. Justin's vision is to revolutionize the field of longevity and improve the quality of life for people around the world.

Alice Gilman is a global leader in longevity innovation and strategic operations, with experience organizing over 80 events across 40+ countries. As a consultant and researcher in longevity labs and startups, she brings deep expertise in investor relations, brand strategy, and operational leadership. Alice co-founded Homespace, securing $500K in funding, and has driven impactful initiatives in AI, biotech, and healthspan-focused ventures. With roles spanning COO, business consulting, and founder residencies, Alice combines entrepreneurial vision and operational excellence to pioneer solutions for living longer, healthier lives.

Ben Nashman is the Founder and CEO of Synex Medical, a company focused on developing non-invasive health monitoring technology using magnetic resonance techniques. Since founding the company in 2017 while still in high school, Ben has led the development of innovative solutions to measure critical blood metabolites non-invasively. His work aims to provide accurate, real-time health data to enable predictive and personalized medicine. Ben's passion for science and technology has driven him to create groundbreaking health monitoring devices that could revolutionize the way we approach healthcare.

Felix Werth is a biochemist and political advocate, best known for founding the Party for Rejuvenation Research in Germany. The party focuses on accelerating the development of regenerative medicine to extend healthy human lifespans. As the party's leader, Felix is dedicated to raising public awareness and support for rejuvenation research, aiming to prevent age-related diseases and promote longer, healthier lives.

John Martin Fischer is a Distinguished Professor of Philosophy at the University of California, Riverside, and a leading contributor to the philosophy of free will and moral responsibility. He is known for his theory of semi-compatibilism, which explores the relationship between free will and moral responsibility. Fischer has also made significant contributions to the metaphysics of death and the philosophy of religion. He has served as President of the American Philosophical Association, Pacific Division, and was elected a Fellow of the American Academy of Arts and Sciences in 2024.

Leo Nissola, MD, is a distinguished immunologist, researcher, and cancer specialist. He serves as the Chief Scientific Officer at FirstBio Research, focusing on drug development and medical intelligence. Dr. Nissola previously worked as a Medical Oncology fellow at MD Anderson Cancer Center, supporting prostate cancer clinical trials. During the COVID-19 pandemic, he advised health officials and contributed epidemiological models used by the White House. A bestselling author of THE IMMUNITY SOLUTION, his innovative work in oncology and immunotherapy has earned international recognition, including collaborations with Nobel Laureates and industry leaders.

Jesse Horwitz is the Co-Founder of Agora and Hubble Contacts, where he has driven innovation in the direct-to-consumer contact lens market. With a strong background in investment analysis, Jesse has previously worked at Columbia Investment Management and Bridgewater Associates. His entrepreneurial journey also includes founding Gadfly Capital. Passionate about transforming industries, he leverages his expertise in finance and strategic investment to create impactful ventures. Through his work at Agora and Hubble, Jesse continues to shape the future of health and consumer-focused innovation.

Marc P. Bernegger is a serial tech entrepreneur with over a decade of experience in the longevity sector. He co-founded Maximon, a longevity company-builder, and Longevity Investors, and launched AltAlpha Digital. Marc holds board positions at CfC St. Moritz and GenTwo. A pioneer in cryptocurrency, he explored Bitcoin in 2012 and was a founding shareholder and board member of Crypto Finance Group, which was acquired by Deutsche Boerse in 2021. Marc’s entrepreneurial journey began with usgang.ch (acquired by Axel Springer) and continued with amiando (acquired by Xing), named “Global Technology Pioneer” by the WEF. He holds a law master’s from the University of Zurich and is an alumni of Singularity University.

Dr. Larry Callahan, a distinguished retired chemist, has made significant contributions to global health through his pioneering work at the FDA. With a Ph.D. in Chemistry from the University of Chicago, his groundbreaking research on the B-Z DNA transition and the synthesis of non-hydrolysable analogs led to advancements in enzymology. At the FDA, Dr. Callahan was a trailblazer in HIV research, identifying the mechanisms behind HIV infectivity and the ineffectiveness of CD4-based therapies. He also spearheaded the development of the ISO 11238 standard. Now Chief Scientist at Trials of Life, he leads efforts to revolutionize drug development and clinical research transparency worldwide.

Alexandrul-Ioan Voda, DPhil, is a passionate leader in regenerative medicine, bioinformatics, and biotech. As CEO of The Cat Health Company, Alex leverages a diverse skill set combining wet-lab and computational sciences to drive advancements in biomedical research. A coding aficionado fluent in Python, R, and Bash, Alex specializes in machine learning, data structures, and algorithms. With a DPhil from the University of Oxford, he has contributed to groundbreaking work in inflammatory bowel disease genetics, aging clocks, and human health. His experience spans both academic and industry sectors, with a strong focus on innovation and scientific leadership.